Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies
2006 ◽
Vol 32
(9)
◽
pp. 922-927
◽
2005 ◽
Vol 94
(3)
◽
pp. 265-272
◽
Keyword(s):
Keyword(s):